COMP <GO>
MANH vs NVDA // FORWARD P/E MULTIPLE
Manhattan Associates Inc. (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: MANH 5
— NVDA 10
▲ FORWARD P/E MULTIPLE LEADER: NVDA
LAST: $248.39 (+3.13%) • MKT CAP: $14.04B
forward-pe
59.3x
LAST: $204.64 (-4.22%) • MKT CAP: $4.93T
forward-pe
17.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MANH VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MANH | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.30% | 74.67% | -18.37 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 65.06% | -45.36 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 47.4x | 23.2x | +24.19 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 2.66% | 2.58% | +0.08 | MANH | /fcf-yield <GO> |
| Operating Margin | 25.90% | 65.21% | -39.31 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 20.30% | 63.66% | -43.36 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 83.38% | -79.68 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 24.06 | 19.52 | +4.54 | MANH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | MANH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.30% | 9.01% | -0.71 | MANH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.2 | 35.1 | +37.15 | MANH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.42 | 2.04 | -0.62 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 59.3x | 17.0x | +42.28 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.04B | $4.93T | -$4.92T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MANH REV | NVDA REV | MANH GROSS % | NVDA GROSS % | MANH FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $1.08B | $130.50B | 56.3% | 75.0% | $374.0M | $60.85B |
| FY 2024 | $1.04B | $60.92B | 54.8% | 72.7% | $286.3M | $27.02B |
| FY 2023 | $928.7M | $26.97B | 44.0% | 56.9% | $204.4M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MANH // BETA 1.42
NVDA // BETA 2.04